Editas Medicine, Inc. short interest in 2023
In 2023, Editas Medicine, Inc.'s disclosed short interest ran from 32.19% of shares outstanding on 13 Jan 2023 to 15.66% on 29 Dec 2023, a change of -16.53 percentage points. The year's high was 32.19% on 13 Jan 2023 and its low 15.66% on 29 Dec 2023, averaging 24.14% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 13.97 days on 31 Aug 2023. Full history: Editas Medicine, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2023 in figures
- Start of year
- 32.19% (13 Jan 2023)
- End of year
- 15.66% (29 Dec 2023)
- Change
- -16.53 pp
- High
- 32.19% (13 Jan 2023)
- Low
- 15.66% (29 Dec 2023)
- Average
- 24.14%
- Highest days to cover
- 13.97 (31 Aug 2023)
- SEC filings marked
- 8
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 32.19% | 10.58 | |
| 31 Jan 2023 | 30.45% | 11.12 | |
| 15 Feb 2023 | 28.60% | 10.93 | |
| 28 Feb 2023 | 27.86% | 11.69 | 10-K filed, results (8-K) |
| 15 Mar 2023 | 30.01% | 13.55 | |
| 31 Mar 2023 | 28.58% | 12.66 | |
| 14 Apr 2023 | 29.01% | 8.77 | |
| 28 Apr 2023 | 27.33% | 11.02 | |
| 15 May 2023 | 29.31% | 8.62 | 10-Q filed, results (8-K) |
| 31 May 2023 | 29.71% | 12.96 | |
| 15 Jun 2023 | 29.91% | 7.12 | |
| 30 Jun 2023 | 28.17% | 6.39 | |
| 14 Jul 2023 | 22.42% | 10.56 | |
| 31 Jul 2023 | 18.92% | 11.76 | |
| 15 Aug 2023 | 17.65% | 9.29 | 10-Q filed, results (8-K) |
| 31 Aug 2023 | 17.77% | 13.97 | |
| 15 Sep 2023 | 18.60% | 11.45 | |
| 29 Sep 2023 | 19.56% | 7.81 | |
| 13 Oct 2023 | 20.12% | 11.20 | |
| 31 Oct 2023 | 20.53% | 12.11 | |
| 15 Nov 2023 | 19.43% | 7.80 | 10-Q filed, results (8-K) |
| 30 Nov 2023 | 19.33% | 8.52 | |
| 15 Dec 2023 | 18.33% | 5.89 | |
| 29 Dec 2023 | 15.66% | 7.01 |
See also: Editas Medicine, Inc.'s full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.